Try our Advanced Search for more refined results

FDA Panel Weighs Safety Issues Of Endo Opioid Painkiller

By Emily Field (March 13, 2017, 9:35 PM EDT) -- A U.S. Food and Drug Administration advisory committee is mulling whether the risks of Endo Pharmaceutical's opioid painkiller Opana ER outweigh its benefits, discussing in meetings Monday and Tuesday whether the pills' reformulation makes them harder to abuse and the drug's connection to an HIV outbreak in Indiana....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!